Go Pro
→ The retirement stock I'd buy before Nvidia today (From Chaikin Analytics) (Ad)tc pixel Free GSK Stock Alerts

GSK (GSK) News Today

GSK logo
$49.29 -0.36 (-0.72%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$49.24 -0.06 (-0.12%)
As of 09/25/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

GSK Latest News

GSK PLC Sponsored ADR (NYSE:GSK) Stock Has Consensus Price Target of $56.50
September 25 at 2:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31047295
GSK PLC Sponsored ADR (NYSE:GSK) Receives Consensus Rating of "Hold" from Brokerages
September 25 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-gsk-plc-sponsored-adr-nyse-gsk-receives-consensus-rating-of-hold-from-brokerages-2026-09-25/
GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity
September 24 at 8:11 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-bets-hutchmed-expand-multi-205949512.html
GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger?
September 24 at 8:11 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-adds-another-cancer-drug-224147376.html
Berenberg Turns Bullish on GSK as its $750 Million Deal Adds to Pipeline Momentum
September 24 at 8:11 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/berenberg-turns-bullish-gsk-750-230854693.html
$3.3 Million in New Philanthropic Commitments for Good Jobs Western North Carolina from The Rockefeller Foundation, John M. Belk Endowment, and NC GSK Foundation
September 24 at 10:09 AM  |  finance.yahoo.comhttps://finance.yahoo.com/economy/policy/articles/3-3-million-philanthropic-commitments-110000615.html
Analyzing BioAge Labs (NASDAQ:BIOA) & GSK (NYSE:GSK)
September 24 at 6:00 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31044598
GSK plc (GSK) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
September 23 at 8:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4949183-gsk-plc-gsk-presents-at-bernstein-insights-healthcare-leaders-and-disruptors-3rd-annual
GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Care
September 23 at 6:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-gsk-bets-on-long-acting-biologics-and-ai-to-reshape-respiratory-care-2026-09-23/
GSK plc (GSK) Presents at Bank of America Global Healthcare Conference 2026 Transcript
September 23 at 1:03 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4948941-gsk-plc-gsk-presents-at-bank-of-america-global-healthcare-conference-2026-transcript
GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take Shape
September 23 at 6:01 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-gsk-targets-40b-sales-as-oncology-push-and-19b-savings-plan-take-shape-2026-09-23/
ViiV Healthcare Partners with Prevention Access Campaign (PAC) to Celebrate 10 Years of U=U and Look to The Future
September 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/viiv-healthcare-partners-prevention-access-120000512.html
PainReform (NASDAQ:PRFX) vs. GSK (NYSE:GSK) Head to Head Survey
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31029240
Baird Financial Group Inc. Buys 26,290 Shares of GSK PLC Sponsored ADR $GSK
September 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-baird-financial-group-inc-buys-26290-shares-of-gsk-plc-sponsored-adr-gsk-2026-09-17/
Berenberg Bank Upgrades GSK (NYSE:GSK) to "Buy"
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027883
GSK (LSE:GSK) Agrees Multiple Myeloma T Cell Deal
September 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-lse-gsk-agrees-multiple-011220850.html
GSK Targets Oncology Growth With Lung, Prostate and Gynecologic Cancer Pipeline
September 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-gsk-targets-oncology-growth-with-lung-prostate-and-gynecologic-cancer-pipeline-2026-09-16/
GSK bolsters oncology pipeline with $750m Chimagen TCE deal
September 15, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/gsk-bolsters-oncology-pipeline-with-750m-chimagen-tce-deal/ar-AA2chvZt
GSK plc (GSK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946686-gsk-plc-gsk-presents-at-morgan-stanley-24th-annual-global-healthcare-conference-transcript
GSK upgraded at Berenberg on growth outlook
September 15, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/gsk-upgraded-at-berenberg-on-growth-outlook/ar-AA2ch4w5
GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
September 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-cuts-641-jobs-vaccine-142359501.html
GSK Inks $750M Deal to Add Experimental Blood Cancer Therapy
September 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-inks-750m-deal-add-152200665.html
GSK (NYSE:GSK) Upgraded by Berenberg Bank to "Buy" Rating
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-gsk-nyse-gsk-upgraded-by-berenberg-bank-to-buy-rating-2026-09-15/
GSK to Acquire Experimental Blood Cancer Therapy From Chimagen in $750 Million Deal
September 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-acquire-experimental-blood-cancer-105548779.html
GSK splashes up to $750m on experimental cancer therapy
September 15, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1098541/gsk-splashes-up-to-750m-on-experimental-cancer-therapy-1098541.html
GSK To Buy T Cell-engager For Multiple Myeloma From Chimagen Biosciences For Up To $750 Mln
September 15, 2026  |  rttnews.comhttps://www.rttnews.com/3690931/gsk-to-buy-t-cell-engager-for-multiple-myeloma-from-chimagen-biosciences-for-up-to-750-mln.aspx
GSK strikes up to $750 million deal for cancer-targeting drug
September 15, 2026  |  reuters.comhttps://www.reuters.com/legal/transactional/gsk-strikes-up-750-million-deal-cancer-targeting-drug-2026-09-15/
Lung cancer: 2 drugs from GSK, BioNTech show improved survival, 94% response
September 14, 2026  |  msn.comhttps://www.msn.com/en-in/news/other/lung-cancer-2-drugs-from-gsk-biontech-show-improved-survival-94-response/ar-AA2ccCEL
GSK Plc Presents Positive Registrational Data To Potentially Expand Jideytro (Zidesamtinib) To First-Line ROS1-Positive Non-Small Cell Lung Cancer
September 14, 2026  |  marketscreener.comM
GSK Presents Jideytro Data for Potential Use in First-Line NSCLC
September 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-presents-jideytro-data-potential-151400953.html
GSK (NYSE:GSK) Shares Gap Up - Should You Buy?
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-gsk-nyse-gsk-shares-gap-up-should-you-buy-2026-09-14/
GSK plans expanded US submission for Jideytro after positive results
September 14, 2026  |  lse.co.ukhttps://www.lse.co.uk/news/gsk-plans-expanded-us-submission-for-jideytro-after-positive-results-cipb07elpsft8ti.html
Data from Greater Bay Area’s 88 million residents to help improve healthcare policy: GSK
September 14, 2026  |  msn.comhttps://www.msn.com/en-xl/money/general/data-from-greater-bay-area-s-88-million-residents-to-help-improve-healthcare-policy-gsk/ar-AA2c9S6K
GSK Reports 94% Response Rate for Lung Cancer Drug Trial
September 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-reports-94-response-rate-075702031.html
GSK PLC Announces Positive Phase III Overall Survival Data For Ris-Rez In Relapsed Small Cell Lung Cancer In China
September 14, 2026  |  marketscreener.comM
GSK's Potential Small-Cell Lung Cancer Drug Meets Primary Endpoint in Late-Stage Trial
September 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-apos-potential-small-cell-075939799.html
GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment
September 13, 2026  |  marketscreener.comM
GSK Targets £1.9B Savings to Fuel Pipeline, Navigate HIV Patent Cliff
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-gsk-targets-19b-savings-to-fuel-pipeline-navigate-hiv-patent-cliff-2026-09-13/
GSK to shut vaccine factory in Germany, putting 641 jobs at risk
September 11, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/gsk-shut-vaccine-factory-germany-putting-641-jobs-risk-2026-09-11/
Vaccine production site in Germany's Dresden to close after 115 years
September 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaccine-production-germanys-dresden-close-230353633.html
GSK slides Thursday, underperforms market
September 10, 2026  |  marketwatch.comhttps://www.marketwatch.com/data-news/gsk-slides-thursday-underperforms-market-64ef4ba9-494e32ceda7f
GSK’s mRNA Flu Vaccine Shows Promise, But Can It Deliver Late-Stage?
September 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsk-mrna-flu-vaccine-shows-013322802.html
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff
September 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/gsks-specialty-medicines-drive-growth-153500750.html
GSK PLC Sponsored ADR $GSK Shares Purchased by Keystone Financial Planning Inc.
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-gsk-plc-sponsored-adr-gsk-shares-purchased-by-keystone-financial-planning-inc-2026-09-10/
GSK PLC Sponsored ADR $GSK Shares Purchased by NewEdge Advisors LLC
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-gsk-plc-sponsored-adr-gsk-shares-purchased-by-newedge-advisors-llc-2026-09-10/
RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold
September 10, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/GSK/pressreleases/4524116/rbc-capital-downgrades-glaxosmithkline-gsk-to-a-hold/
GSK Wins Japan Approval For Ready-to-Use Shingrix Prefilled Syringe
September 10, 2026  |  rttnews.comhttps://www.rttnews.com/3689853/gsk-wins-japan-approval-for-ready-to-use-shingrix-prefilled-syringe.aspx
GSK PLC Receives Approval For Shingrix Prefilled Syringe Presentation In Japan
September 10, 2026  |  marketscreener.comM
GSK plc (GSK) Presents at Bernstein's 23rd Annual Pan-European Strategic Decisions Conference Transcript
September 9, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4944386-gsk-plc-gsk-presents-at-bernsteins-23rd-annual-pan-european-strategic-decisions-conference
Waverly Advisors LLC Boosts Stake in GSK PLC Sponsored ADR $GSK
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-waverly-advisors-llc-boosts-stake-in-gsk-plc-sponsored-adr-gsk-2026-09-09/

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment
▼
0.51

0.73
▲
Average
Healthcare
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week
▼
11

7
▲
GSK Articles
Average Week

GSK Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
-75%
Page Views
3,617
-22%
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for GSK dated 9/25/2026.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
Analyst nicknamed “The Prophet” issues new warning for America
Whitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...
Stansberry Research | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
A Scary Development Every AI Investor Needs to Take Note Of
Micron surged over 500% in the past year, Intel climbed more than 250%, and AMD soared over 250% - but a $194 ...
Weiss Ratings | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel